Viridian Therapeutics, Inc.

VRDN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 Dec 12, 2023
SC 13G Dec 8, 2023 SC 13G
144 Dec 7, 2023
144 Dec 1, 2023
S-3ASR Nov 30, 2023 S-3ASR
144 Nov 16, 2023
4 Nov 13, 2023 4
10-Q Nov 13, 2023 10-Q
8-K Nov 13, 2023 8-K
SC 13D/A Nov 3, 2023 SC 13D/A
8-K Nov 2, 2023 8-K
4 Nov 1, 2023 4
3 Nov 1, 2023 3
4 Nov 1, 2023 4
4 Nov 1, 2023 4
3 Nov 1, 2023 3
8-K Oct 30, 2023 8-K
4 Sep 25, 2023 4
3 Sep 25, 2023 3
8-K Sep 25, 2023 8-K
3 Sep 19, 2023 3
8-K Sep 12, 2023 8-K
S-8 Aug 8, 2023 S-8
10-Q Aug 8, 2023 10-Q
S-3ASR Jul 24, 2023 S-3ASR
← Newer Page 8 of 33 · 815 filings Older →